A G C T
Live / Registered — Registered and renewed (as of 06 Dec 2022)
What this means for you
Registered since 19 Jun 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Jun 2022).
Record
- Serial number
- 85441949
- Registration number
- 4160543
- Mark type
- Design + words
- Filed
- 07 Oct 2011
- Published for opposition
- 03 Apr 2012
- Registered
- 19 Jun 2012
- Next maintenance due
- 19 Jun 2022
- Attorney of record
- Susan M. Natland
Goods and services
- Class 001 — Chemicals: Reagents and reagent kits comprising nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of scientific, diagnostic and clinical research
Owner
- Illumina, Inc., San Diego, CA, US
- Illumina, Inc., San Diego, CA, US
- Illumina, Inc., San Diego, CA, US
Prosecution history
- 29 Oct 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Dec 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 06 Dec 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 06 Dec 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 06 Dec 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 May 2022 — TEAS SECTION 8 & 9 RECEIVED
- 19 Jun 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 21 Aug 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Aug 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jun 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED